bimatoprost ophthalmic solution 0.03%"ts" (ビマトプロスト点眼液0.03%「ts」)
rohto nitten co., ltd. - bimatoprost - limpid and colorless sterile aqueous eye solution, (cap) deep green, (bottle) white translucent, (accompanying bag) clear [shading]
bimatoprost ophthalmic solution 0.03%"nitten" (ビマトプロスト点眼液0.03%「日点」)
rohto nitten co., ltd. - bimatoprost - limpid and colorless sterile aqueous eye solution, (cap) peacock green, (bottle) white translucent, (accompanying bag) clear [shading]
bimatoprost ophthalmic solution 0.03% "sec" (ビマトプロスト点眼液0.03%「sec」)
santen pharmaceutical co.,ltd. - bimatoprost - limpid and colorless, ophthalmic solution, 2.5ml, (bottle) clear and colorless, (cap) white [label of vivid green wave design]
ganfort
allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
ganfort
abbvie biopharmaceuticals ltd, israel - bimatoprost; timolol as maleate - eye drops, solution - bimatoprost 0.3 mg/ml; timolol as maleate 5 mg/ml - timolol - timolol - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
lumigan
abbvie limited - bimatoprost 0.3 mg/ml; - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
ganfort® 0.3/5
abbvie limited - bimatoprost 0.3 mg/ml; ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol; - eye drops, solution - active: bimatoprost 0.3 mg/ml timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide
ganfort eye drops
abbvie pte. ltd. - bimatoprost; timolol maleate 6.8mg/ml eqv. to timolol base - solution, sterile - 0.3mg/ml - bimatoprost 0.3mg/ml; timolol maleate 6.8mg/ml eqv. to timolol base 5mg/ml
ganfort pf 0.3/5
abbvie limited - bimatoprost 300 µg/ml; ; timolol maleate 5 mg/ml; - eye drops, solution - 300mcg/ml & 5mg/ml - active: bimatoprost 300 µg/ml timolol maleate 5 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
lumigan pf
abbvie limited - bimatoprost 0.3 mg/ml; - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.